September 20, 2017
Lombard Medical reports that Jonathan Hornsby brings over 20 years of experience in the endovascular aortic repair business.
Jonathan Hornsby has been instrumental in several product launches, including Medtronic’s Endurant stent graft and Endologix’ Nellix endovascular aneurysm sealing system. He joins Lombard from Endologix (NASDAQ: ELGX) where he served as Sales Director and European Aortic Therapy Director. Prior to his five years at Endologix, Hornsby spent 12 years in Medtronic’s endovascular business.
Kurt Lemvigh, Lombard Medical Chief Executive Officer, commented, “Jonathan is a world-class executive and a welcome addition to our team. He brings a combination of extensive endovascular clinical and UK market knowledge to Lombard. We anticipate he will greatly strengthen our direct sales efforts in the UK and will be a valuable asset in support of our international distribution activities.”
Hornsby stated, “This role is a great opportunity for me to be part of an agile company with a vision to capitalize on the emerging Asian markets and other international geographies. The fact that we are UK-based provides our local customers with an opportunity to actually see the product being manufactured and engage with our workforce. I’m delighted to become part of this committed team.”